Potency of progestogens used in hormonal therapy: Toward understanding differential actions

@article{Hapgood2014PotencyOP,
  title={Potency of progestogens used in hormonal therapy: Toward understanding differential actions},
  author={J. Hapgood and D. Africander and R. Louw and R. Ray and J. Rohwer},
  journal={The Journal of Steroid Biochemistry and Molecular Biology},
  year={2014},
  volume={142},
  pages={39-47}
}
Progestogens are widely used in contraception and in hormone therapy. Biochemical and molecular biological evidence suggests that progestogens differ widely in their affinities and transcriptional effects via different steroid receptors, and hence cannot be considered as a single class of compounds. Consistent with these observations, recent clinical evidence suggests that, despite their similar progestogenic actions, these differences underlie different side-effect profiles for cardiovascular… Expand
View on Elsevier
doi.org
50 Citations
Highly Influential Citations
3
Background Citations
14
Methods Citations
3

50 Citations

Citation Type

Citation Type

Pharmacokinetics, metabolism and serum concentrations of progestins used in contraception.
Differential metabolism of clinically-relevant progestogens in cell lines and tissue: Implications for biological mechanisms
Progestogens as a component of menopausal hormone therapy: the right molecule makes the difference
Molecular basis and tissue specificity of the progestin effect
Fourth-Generation Progestins Inhibit 3β-Hydroxysteroid Dehydrogenase Type 2 and Modulate the Biosynthesis of Endogenous Steroids
Progestogen safety and tolerance in hormonal replacement therapy
Differential Glucocorticoid Receptor‐Mediated Effects on Immunomodulatory Gene Expression by Progestin Contraceptives: Implications for HIV‐1 Pathogenesis
A direct comparison of the transcriptional activities of progestins used in contraception and menopausal hormone therapy via the mineralocorticoid receptor.
Recent advances in structure of progestins and their binding to progesterone receptors
Comparing the androgenic and estrogenic properties of progestins used in contraception and hormone therapy.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 62 REFERENCES
Molecular mechanisms of steroid receptor-mediated actions by synthetic progestins used in HRT and contraception
Progestogens used in postmenopausal hormone therapy: differences in their pharmacological properties, intracellular actions, and clinical effects.
Multiple nuclear receptor signaling pathways mediate the actions of synthetic progestins in target cells
Pharmacology of estrogens and progestogens: influence of different routes of administration
  • H. Kuhl
  • Medicine
  • Climacteric : the journal of the International Menopause Society
  • 2005
Drospirenone: pharmacology and pharmacokinetics of a unique progestogen.
Not all progestins are the same: implications for usage.
The preclinical biology of a new potent and selective progestin: trimegestone
The pharmacological profile of a novel norpregnance progestin (trimegestone).
All progestins are not created equal
Assessment of the potency of orally administered progestins in women.
...
1
2
3
4
5
...